I am Medical Oncologist and Ph.D. student at the University of Bologna since 2023. I conduct clinical and scientific activities in the field of thoracic oncology. My main research interests focus on identifying biomarkers capable of improving the personalization of therapies and the survival of patients with lung cancer. In November 2025, I moved to New York, USA, to start as a Staff Scientist at the Memorial Sloan Kettering Cancer Center.
Education
I have graduated with honors in Medicine and Surgery in 2017 from the University of Parma, and I obtained a specialization diploma in Medical Oncology from the University of Bologna in 2023. I have been a researcher at the Dana-Farber Cancer Institute in Boston, an affiliate hospital of Harvard University, from July 2022 to November 2023. Then, I continued collaborating with the Dana-Farber Cancer Institute as a Research Affiliate remotely, until June 2025. In 2023, I was selected by the International Association for the Study of Lung Cancer (IASLC) for the IASLC Academy.
Scientific Activities
I am engaged in national and international research projects. I have authored of more than 110 studies in peer-reviewed international journals, including first authorships in The Lancet Oncology, Annals of Oncology, and Journal of Thoracic Oncology. I have presented scientific works at various international conferences, including the World Conference of Lung Cancer (WCLC) in 2021 and 2023, American Society of Clinical Oncology (ASCO) in 2023, 2024, and 2025, Targeted Therapies in Lung Cancer in 2023, 2025, and 2026, European Lung Cancer Congress (ELCC) in 2024, European Society for Medical Oncology (ESMO) in 2024.
Membership in Scientific and Editorial Committees
I have been a member of the "Career Development" committee of the International Association for the Study of Lung Cancer (IASLC) since 2023. I was selected as a meeting correspondent by the Society for Immunotherapy of Cancer in 2023, serving as an expert envoy at the "ESMO Immuno-Oncology" congress in Geneva, Switzerland. I have served as associate editor for the journal ‘Cancer Immunology, Immunoherapy,’ and review editor for 'Frontiers in Oncology' and 'Frontiers in Immunology.'
Awards
In 2023, I received the Educational Award from the International Association for the Study of Lung Cancer (IASLC) for a study on lung cancer presented at the "Targeted Therapies of Lung Cancer" Congress held in Santa Monica (California, US). I have also received the award for the IASLC Academy 2023, held in Singapore. In 2023, I received the Fondazione F. Calabresi award for the best publication by a young Italian researcher in 2023 during the "Grandangolo. Un anno di Oncologia" congress held in Genoa. In 2024, I received a Merit Travel Grant for a study on lung cancer presented at the European Lung Cancer Congress (ELCC). In 2025, I received another Educational Award from the IASLC for a study on lung cancer presented at the "Targeted Therapies of Lung Cancer" Congress held in Huntington Beach (California, US)
